Author(s): Pontarelli A; Wilds CJ;
The introduction of chemical modifications on the nucleic acid scaffold has allowed for the progress of antisense oligonucleotides (ASOs) in the clinic for the treatment of a variety of disorders. In contribution to the repertoire of gene-silencing nucleic ...
Article GUID: 36857293
- Page 1 / 1 -